Halo Whippany site Halo Pharma is expanding its manufacturing capabilities at its Whippany, NJ, facility with the addition of ...

The eighth-largest pharmaceuticals company in the world, Swiss-based Novartis, is planning a $280 million manufacturing plant ...

Over 500 industry leaders gathered at the Dublin Royal Convention Centre to celebrate excellence in Ireland’s pharma sector ...

Virginia is becoming a national force in advanced pharmaceutical manufacturing, attracting $12.5 billion in new investment ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

Mayne Pharma Group ( ($AU:MYX) ) has provided an update. Mayne Pharma has officially opened its expanded manufacturing facility in Salisbury, ...

Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...

Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, ...

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union. Still, as with previous communications on the ...